Filing Details
- Accession Number:
- 0000899243-17-004353
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-16 15:21:05
- Reporting Period:
- 2017-02-14
- Filing Date:
- 2017-02-16
- Accepted Time:
- 2017-02-16 15:21:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1211150 | A Douglas Batt | Parexel International Corporation 195 West Street Waltham MA 02451 | Svp, General Counsel & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-14 | 5,500 | $12.55 | 66,979 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-14 | 5,500 | $65.39 | 61,479 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-02-14 | 5,500 | $0.00 | 5,500 | $12.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-09-09 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $65.36- $65.44. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- Fully exercisable.